July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

1/2
Please reload

Featured Posts

We're headed to Nashville!

May 3, 2018

Our team is excited to attend the 20th Biennial FIRST National Conference in Nashville, TN next month.  This will be our second time attending and something we continue to look forward to every couple years.  Not only is it a great opportunity to learn from a variety of stakeholders during the formal presentations, we enjoy getting to know the patient community more directly in an informal setting.   

 

We are very excited to announce that our President and Co-Founder, Zach Rome, will be sitting on a panel sharing insights on what it's like to develop new medications for patients with rare diseases.  More details on this to follow.


If you are interested in learning more about FIRST and their upcoming conference, please follow the link below.

 

http://www.firstskinfoundation.org/nashville

Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC